HLS Therapeutics (HLTRF) Q2 2024 Earnings

9MayConfirmed
May 22
Aug 22
Nov 22
Q2 2024
-0.28
-0.21
-0.14
-0.07

Details

Expected EPS
-0.1587
Actual EPS
-0.19
Surprise EPS
-0.03
Surprise Percent
+19.72%

Description

HLS Therapeutics (HLTRF) has reported earnings of -0.19 per share for Q2 2024.

0 Comments

Share your thoughts